If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

Dr. David Boulware is an infectious disease physician-scientist with formal training in public health, clinical trials, and tropical medicine.  As a translational researcher, Dr. Boulware combines his clinical research training with basic science investigations into disease pathogenesis. His primary research interests are in meningitis in resource-limited areas including diagnosis, prevention, treatment, and quality improvement initiatives incorporating cost-effectiveness analyses in order to translate knowledge into improved care.

Dr. Boulware’s current research is focused on improving the clinical outcomes of HIV-infected persons with meningitis.  Cryptococcal meningitis is the second most common AIDS-defining opportunistic infection in Sub-Saharan Africa and the most common cause of adult meningitis. Why Cryptococcus?  During 2016, cryptococcal meningitis accounts for ~70% of adult meningitis in Uganda. Even in the U.S., the estimated incidence of 1.1 hospitalizations for cryptococcal meningitis makes this more common than all causes of bacterial meningitis combined. Prevention with targeted cryptococcal antigen screening and preemptive therapy for early disseminated Cryptococcus infection is of great interest with ongoing clinical studies and trials. Diagnostics for TB meningitis have become an emerging area of interest and research.  Dr. Boulware has active research collaborations in Uganda, South Africa, Tanzania, and Ethiopia leading a multidisciplinary, international research team which is highly collaborative in working with others.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 6 Similar Profiles
Cryptococcal Meningitis Medicine & Life Sciences
HIV Medicine & Life Sciences
Immune Reconstitution Inflammatory Syndrome Medicine & Life Sciences
Cerebrospinal Fluid Medicine & Life Sciences
Uganda Medicine & Life Sciences
Meningeal Tuberculosis Medicine & Life Sciences
Antigens Medicine & Life Sciences
Meningitis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2009 2021

Capacity Building
Cryptococcosis
Research
Cryptococcal Meningitis
Fluconazole
Africa South of the Sahara
Therapeutics
Non-Randomized Controlled Trials
Meningitis
Acquired Immunodeficiency Syndrome
HIV

Research Output 2003 2018

Absence of cerebrospinal fluid pleocytosis in tuberculous meningitis is a common occurrence in HIV co-infection and a predictor of poor outcomes

Cresswell, F. V., Bangdiwala, A. S., Meya, D. B., Bahr, N. C., Vidal, J. E., Török, M. E., Thao, L. T. P., Thwaites, G. E. & Boulware, D. R., Mar 1 2018, In : International Journal of Infectious Diseases. 68, p. 77-78 2 p.

Research output: Contribution to journalLetter

Meningeal Tuberculosis
Leukocytosis
Coinfection
HIV Infections
Cerebrospinal Fluid

Antimicrobial drug resistance in blood culture isolates at a tertiary hospital, Uganda

Kajumbula, H., Fujita, A. W., Mbabazi, O., Najjuka, C., Izale, C., Akampurira, A., Aisu, S., Lamorde, M., Walwema, R., Bahr, N. C., Meya, D. B., Boulware, D. R. & Manabe, Y. C., Jan 1 2018, In : Emerging infectious diseases. 24, 1, p. 174-175 2 p.

Research output: Contribution to journalLetter

Uganda
Microbial Drug Resistance
Tertiary Care Centers
Africa South of the Sahara
Microbiology
Uganda
HIV
Antigens
Fluconazole
Therapeutics

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda

Lofgren, S. M., Nalintya, E., Meya, D. B., Boulware, D. R. & Rajasingham, R., Aug 1 2018, In : Medicine. 97, 31, p. e11722

Research output: Contribution to journalArticle

Uganda
Antigens
HIV
Therapeutics
Fluconazole

Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?

Rajasingham, R., Meya, D. B. & Boulware, D. R., Jul 1 2018, In : HIV Medicine. 19, 6, p. e64-e65

Research output: Contribution to journalLetter

Sertraline
Fluconazole
Rifampin